SCHEMBL30634278

SCHEMBL30634278

COC(=O)/C=C/c1ccc2cc(C)cnc2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
KMT2A Q03164 1/20 0.60
TTR P02766 1/20 0.51
APP P05067 1/20 0.51
PTPN1 P18031 1/20 0.49
FDPS P14324 2/20 0.48
EPHX2 P34913 1/20 0.48
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
TYR P14679 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
CA14 Q9ULX7 1/20 0.48
ALDH1A1 P00352 2/20 0.47
MAPT P10636 2/20 0.47
JAK2 O60674 1/20 0.47
GAA P10253 1/20 0.47
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26791222 1.00 KDM4E (0.60) KDM4ESMN1; SMN2KMT2ATTRAPP
SCHEMBL26787976 0.87 TTR (0.56) KDM4ESMN1; SMN2KMT2ATTRAPP
SCHEMBL30634265 0.87 TTR (0.56) KDM4ESMN1; SMN2KMT2ATTRAPP
SCHEMBL30634252 0.85 KDM4E (0.47) KDM4ESMN1; SMN2KMT2ATTRAPP
SCHEMBL26634020 0.85 RAB9A (0.55) KDM4ESMN1; SMN2KMT2ATTRAPP
SCHEMBL30634311 0.82 APP (0.58) KDM4ESMN1; SMN2KMT2ATTRAPP
SCHEMBL30634276 0.80 APP (0.60) KDM4ESMN1; SMN2KMT2ATTRAPP
SCHEMBL10312567 0.80 APP (0.59) KDM4ESMN1; SMN2KMT2ATTRAPP
SCHEMBL8890230 0.78 KMT2A (0.54) KDM4ESMN1; SMN2KMT2ATTRAPP
SCHEMBL14328057 0.78 KDM4E (0.71) KDM4ESMN1; SMN2KMT2ATTRAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250270187-A1 MOLECULAR EDITING OF MULTIPLE C-H BONDS LEVERAGING RECOGNITION OF DISTANCE, GEOMETRY AND CHIRALITY THE SCRIPPS RESEARCH INSTITUTE 2025-08-28 US disclosed
WO-2023212565-A2 MOLECULAR EDITING OF MULTIPLE C-H BONDS BY LEVERAGING RECOGNITION OF DISTANCE, GEOMETRY AND CHIRALITY THE SCRIPPS RESEARCH INSTITUTE (US) 2023-11-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250270187-A1 MOLECULAR EDITING OF MULTIPLE C-H BONDS LEVERAGING RECOGNITION OF DISTANCE, GEOMETRY AND CHIRALITY CYCS, CYC1, CDA KDM4E 1832/4885SMN1; SMN2 1814/4885KMT2A 2811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.